Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200416514> ?p ?o ?g. }
- W4200416514 endingPage "441" @default.
- W4200416514 startingPage "427" @default.
- W4200416514 abstract "Benign prostatic hyperplasia (BPH) is a progressive expansion of peri-urethral prostate tissue common in aging men. Patients with enlarged prostates are treated with 5-alpha reductase inhibitors (5ARIs) to shrink prostate volume by blocking the conversion of testosterone to dihydrotestosterone (DHT). A reduction in DHT levels can elicit atrophy and apoptosis of prostate secretory luminal cells, which results in a favorable clinical response characterized by improved lower urinary tract symptoms. However, the histologic response to 5ARI treatment is often heterogeneous across prostate acini and lower urinary tract symptoms can persist to require surgical intervention. We used two spatial profiling approaches to characterize gene expression changes across histologically normal and atrophied regions in prostates from 5ARI-treated men. Objective transcriptomic profiling using the Visium spatial gene expression platform showed that 5ARI-induced atrophy of prostate luminal cells correlated with reduced androgen receptor signaling and increased expression of urethral club cell genes including LTF, PIGR, OLFM4, SCGB1A1, and SCGB3A1. Prostate luminal cells within atrophied acini adapted to decreased DHT conditions by increasing NF-κB signaling and anti-apoptotic BCL2 expression, which may explain their survival. Using GeoMx digital spatial profiling with a probe set to assess ~18 000 RNA targets, we confirmed that atrophied acini expressing SCGB3A1 displayed higher levels of club cell markers compared with histologically normal acini with NKX3-1 expression. In addition, club-like cells within regions of 5ARI-induced atrophy closely resembled true club cells from the prostatic urethra. A comparison of histologically normal regions from 5ARI-treated men and histologically normal regions from untreated men revealed few transcriptional differences. Taken together, our results describe a heterogeneous response to 5ARI treatment where cells in atrophied acini undergo an adaptation from a prostate secretory luminal to a club cell-like state in response to 5ARI treatment. © 2021 The Pathological Society of Great Britain and Ireland." @default.
- W4200416514 created "2021-12-31" @default.
- W4200416514 creator A5015037219 @default.
- W4200416514 creator A5015243761 @default.
- W4200416514 creator A5049019006 @default.
- W4200416514 creator A5073118929 @default.
- W4200416514 creator A5074919849 @default.
- W4200416514 creator A5079605065 @default.
- W4200416514 creator A5083251139 @default.
- W4200416514 creator A5084948708 @default.
- W4200416514 creator A5085518801 @default.
- W4200416514 creator A5088939859 @default.
- W4200416514 date "2022-02-03" @default.
- W4200416514 modified "2023-10-15" @default.
- W4200416514 title "5‐Alpha reductase inhibitors induce a prostate luminal to club cell transition in human benign prostatic hyperplasia" @default.
- W4200416514 cites W107210901 @default.
- W4200416514 cites W1536846849 @default.
- W4200416514 cites W1966010244 @default.
- W4200416514 cites W2004606463 @default.
- W4200416514 cites W2008199535 @default.
- W4200416514 cites W2016381211 @default.
- W4200416514 cites W2031089158 @default.
- W4200416514 cites W2043118554 @default.
- W4200416514 cites W2051173965 @default.
- W4200416514 cites W2069974481 @default.
- W4200416514 cites W2087451735 @default.
- W4200416514 cites W2099618765 @default.
- W4200416514 cites W2103017472 @default.
- W4200416514 cites W2121759271 @default.
- W4200416514 cites W2122734862 @default.
- W4200416514 cites W2130410032 @default.
- W4200416514 cites W2131648113 @default.
- W4200416514 cites W2138063658 @default.
- W4200416514 cites W2145449065 @default.
- W4200416514 cites W2161057551 @default.
- W4200416514 cites W2167279371 @default.
- W4200416514 cites W2396961956 @default.
- W4200416514 cites W2512594468 @default.
- W4200416514 cites W2742739430 @default.
- W4200416514 cites W2768448209 @default.
- W4200416514 cites W2949177718 @default.
- W4200416514 cites W2950114058 @default.
- W4200416514 cites W2966060845 @default.
- W4200416514 cites W2999065750 @default.
- W4200416514 cites W3021988909 @default.
- W4200416514 cites W3023701177 @default.
- W4200416514 cites W3033373027 @default.
- W4200416514 cites W3038532786 @default.
- W4200416514 cites W3164692211 @default.
- W4200416514 cites W3175990841 @default.
- W4200416514 cites W4379365691 @default.
- W4200416514 cites W2136174497 @default.
- W4200416514 doi "https://doi.org/10.1002/path.5857" @default.
- W4200416514 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34928497" @default.
- W4200416514 hasPublicationYear "2022" @default.
- W4200416514 type Work @default.
- W4200416514 citedByCount "18" @default.
- W4200416514 countsByYear W42004165142021 @default.
- W4200416514 countsByYear W42004165142022 @default.
- W4200416514 countsByYear W42004165142023 @default.
- W4200416514 crossrefType "journal-article" @default.
- W4200416514 hasAuthorship W4200416514A5015037219 @default.
- W4200416514 hasAuthorship W4200416514A5015243761 @default.
- W4200416514 hasAuthorship W4200416514A5049019006 @default.
- W4200416514 hasAuthorship W4200416514A5073118929 @default.
- W4200416514 hasAuthorship W4200416514A5074919849 @default.
- W4200416514 hasAuthorship W4200416514A5079605065 @default.
- W4200416514 hasAuthorship W4200416514A5083251139 @default.
- W4200416514 hasAuthorship W4200416514A5084948708 @default.
- W4200416514 hasAuthorship W4200416514A5085518801 @default.
- W4200416514 hasAuthorship W4200416514A5088939859 @default.
- W4200416514 hasBestOaLocation W42004165142 @default.
- W4200416514 hasConcept C104317684 @default.
- W4200416514 hasConcept C121608353 @default.
- W4200416514 hasConcept C126322002 @default.
- W4200416514 hasConcept C126894567 @default.
- W4200416514 hasConcept C134018914 @default.
- W4200416514 hasConcept C150194340 @default.
- W4200416514 hasConcept C162317418 @default.
- W4200416514 hasConcept C2775874879 @default.
- W4200416514 hasConcept C2776235491 @default.
- W4200416514 hasConcept C2777562237 @default.
- W4200416514 hasConcept C2777911890 @default.
- W4200416514 hasConcept C2777957205 @default.
- W4200416514 hasConcept C2778878792 @default.
- W4200416514 hasConcept C2779478474 @default.
- W4200416514 hasConcept C2779881493 @default.
- W4200416514 hasConcept C2780192828 @default.
- W4200416514 hasConcept C2910366748 @default.
- W4200416514 hasConcept C502942594 @default.
- W4200416514 hasConcept C55493867 @default.
- W4200416514 hasConcept C61367390 @default.
- W4200416514 hasConcept C71315377 @default.
- W4200416514 hasConcept C71924100 @default.
- W4200416514 hasConcept C86803240 @default.
- W4200416514 hasConceptScore W4200416514C104317684 @default.
- W4200416514 hasConceptScore W4200416514C121608353 @default.
- W4200416514 hasConceptScore W4200416514C126322002 @default.